Now is the time to analyze and manage costs and investments, which will be crucial to capitalize on as we head into an upswing in business. Photo by Hero Images

Although the world may be going back to normal and it feels like we can see the light at the end of the tunnel, business owners across the country are seeing lasting negative effects of the COVID-19 pandemic on their companies. Especially in the restaurant industry, local business owners are having to rely on government aid to make sure employees and rent are paid, keeping stress levels very high.

Our company, Cerboni, is a financial firm that works with clients to relieve the burden business owners face by taking things like back-office work, inventory management and more off their plate to give them the freedom to focus on their trade. To help alleviate some of this stress, we are taking an in-depth look at some of the options available to business owners working to navigate government aid applications, along with opportunities for future prosperity.

Don’t let financial opportunities fall through the cracks

While business owners are often pulled in many directions, it's important to make sure you are taking advantage of any help that is available to you. Currently, the Restaurant Revitalization Fund, Employee Retention Credit and the Paycheck Protection Program are available to qualifying business owners. Taking the time to figure out which opportunities you should apply for and which ones are the best fit, will greatly benefit your company in the long run.

What to know about the Restaurant Revitalization Fund

The Restaurant Revitalization Fund provides funding equal to pandemic-related revenue loss up to $10 million per business and no more than $5 million per physical location for eligible restaurants, bars and other qualifying businesses where onsite sales to the public make-up at least 33 percent of gross sales receipts. Recipients have two years to use these funds, and the money can be used for business expenses such as payroll, mortgage obligations, rent payments, maintenance expenses, construction of outdoor seating and more.

The most important thing to know about this fund is how to calculate the funding amount. For those operating prior to or on January 1, 2019, applicants will calculate the 2019 gross receipts minus 2020 gross receipts minus PPP loan amounts. Applicants that began operations partially through 2019 should average the 2019 monthly gross receipts and multiply by 12, subtract 2020 gross receipts and then subtract PPP loan amounts. Businesses that began operations between January 1, 2020 and March 10, 2021, or those who have not yet opened but have incurred eligible expenses as of March 11, 2021, should calculate the amount spent on eligible expenses between February 15, 2020 and March 11, 2021, subtract 2020 gross receipts, then subtract 2021 gross receipts (through March 11, 2021) and, lastly, subtract PPP loan amounts.

Utilizing Employee Retention Credit

The Employee Retention Credit is a fully refundable tax credit for "qualified wages" paid to employers that were ordered to suspend operations fully or partially during 2020 or experienced a significant decline (below 50%) in gross receipts during the calendar quarter. The purpose of the Employee Retention Credit is to encourage employers to keep employees on payroll during the pandemic. Recipients can receive up to $5,000 for each full-time employee retained between March 13, 2020 and December 31, 2020 and up to $14,000 for each employee retained between January 1, 2021 and June 30, 2021. Qualified wages depend on the size of the operation. If the employer averaged more than 100 employees in 2019, the wages are only paid for the time the employee is not providing services. If the employer has less than 100 employees, the wages are paid to any employee during any period of hardship due to the pandemic. Recipients of PPP are not eligible for Employee Retention Credit.

Future prosperity

The restaurant industry was greatly impacted by the pandemic, but if you survived, you now have a great opportunity ahead of you. People are starting to return to a sense of normalcy and want to get back to enjoying things like events, shopping, eating out with friends and family and more.

Now is the time to analyze and manage costs and investments, which will be crucial to capitalize on as we head into an upswing in business. Understanding all of these financial nuances can seem daunting, so Cerboni can assist with knowing how to make the right investments in order to increase sales and profitability – this could be through marketing and advertising, changing up the menu to minimize cost of goods sold or managing operating costs.

For those who want to grow their footprint, the market is hot, and it's the perfect time to expand your market presence through negotiation of better lease terms and lower interest rates. Use this time to strategize on how to not only cut costs, but how to increase sales, and how to ultimately grow.

------

Maria Degaine and Joshua Santana are co-founders of Houston-based Cerboni.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Pharma giant considers Houston for $1B manufacturing campus

in the works

Another pharmaceutical giant is considering Houston’s Generation Park for a manufacturing hub.

According to a recent filing with the Texas Jobs, Energy, Technology and Innovation (JETI) program, Bristol Myers Squibb Co. is considering the northeast Houston management district for a new $1 billion multi-modal pharmaceutical manufacturing campus.

If approved, the campus, known as Project Argonaut, could create 489 jobs in Texas by 2031. Jobs would include operations technicians, engineering roles, administrative and management roles, production specialists, maintenance support, and quality control/assurance. The company predicts annual average wages for these positions to be around $96,000, according to the filing.

The project currently includes the 600,000-square-foot facility, but according to the filing, Bristol Myers Squibb “envisions this site growing in scale and capability well beyond its opening configuration."

The Texas JETI program offers companies temporary school property tax limitations in exchange for major capital investment and job creation. E.R. Squibb & Sons LLC applied for a 10-year tax abatement agreement in the Sheldon Independent School District.

The agreement promises a $ 1 billion investment. Construction would begin in 2027 and wrap in 2029.

“The proposed project reflects [Bristol Myers Squibb Co.’s] enduring commitment to bringing innovative medicines to patients and ensuring the long-term supply reliability they depend on,” the filing says. “The proposed project is purpose-built to support and manufacture medicines spanning multiple therapeutic areas and modalities, positioning the site as a long-term launch and commercial campus for decades to come. These medicines will provide therapies to the [Bristol Myers Squibb Co.’s] patients located in markets both nationally and internationally.”

The Fortune 100 company is considering 16 other cities for the new manufacturing facility in the Central and Eastern markets in the U.S. According to the Houston Chronicle, Bristol Myers Squibb Co is still in the “evaluation process” for its potential manufacturing site.

Last fall, Eli Lilly and Co. selected Generation Park for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

Houston health tech co. lands NIH grant for AI cancer prediction tool

fresh funding

Houston-based CellChorus and Stanford Medicine were recently awarded a Phase I Small Business Innovation Research grant for the company's AI platform to test how certain cancer patients will respond to therapies.

The funding comes from the National Cancer Institute of the National Institutes of Health. According to a filing, the grant totaled just under $400,000.

CellChorus, which spun out from the University of Houston’s Technology Bridge, has developed TIMING (Time-lapse Imaging Microscopy In Nanowell Grids), which analyzes the behavior of thousands of individual immune cells over time and can identify early indicators of treatment success or failure.

The company will work with Stanford's Dr. David Miklos and Dr. Saurabh Dahiya, who have built the Bone Marrow Transplantation and Cell Therapy Biobank. The biobank manages and stores biological samples from patients treated at their clinic and in clinical trials.

"Predicting which patients will achieve durable responses after CAR-T therapy remains one of the most important challenges in the field,” Miklos said in a news release. “We aim to uncover functional cellular signatures that can guide treatment decisions and improve patient outcomes.”

The project will specifically profile cells from patients with relapsed/refractory large B-cell lymphoma (r/rLBCL). According to CellChorus, only about half of r/rLBCL patients who receive CAR-T therapy "achieve a durable, long-term remission." Others do not respond to therapy or experience relapse.

“The sooner we know whether a cancer therapy is working, the better. To maximize patient benefit, we need technology that can provide a robust and early prediction of response to therapy. The technology needs to be scalable, cost-efficient, and capable of rapid turnaround times,” Rebecca Berdeaux, chief scientific officer of CellChorus, added in the release. “We are excited to work with Drs. David Miklos and Saurabh Dahiya and their colleagues on this very important project.”

CellChorus has previously received SBIR grants from federal agencies, including a $2.5 million award in 2024 from its National Center for Advancing Translational Sciences (NCATS) and a $2.3 million SBIR Fast-Track award from the National Institute of General Medical Sciences in 2023.

Houston museum showcases America's founding documents in rare exhibit

Experience History

As the United States prepares to celebrate its 250th birthday, Houstonians have a chance to see rare documents from the founding of the nation. Freedom Plane National Tour: Documents That Forged a Nation, presented by the National Archives Foundation, will be on display at the Houston Museum of Natural Science through Monday, May 25.

The collection includes a rare engraving of the original Declaration of Independence; official Oaths of Allegiance signed by George Washington, Aaron Burr, and Alexander Hamilton; a draft of the Bill of Rights; the Treaty of Paris, the documented that recognized America's independence from Great Britain; and the tally of votes approving the Constitution.

The National Archives specifically chose Houston as one of only eight cities in the country to host the exhibit as a means to help the documents reach a wider audience outside of the main hub of semiquincentennial events in New England and the Washington, D.C. area.

"One of the things we decided when we put the tour together because we wanted to be off the East Coast," said Patrick Madden, CEO of the National Archives Foundation, who was onsite for the exhibit's opening in Houston. "There's a lot of 250th celebration stuff happening in the original 13 colonies. How do we get it to major markets where larger numbers of people can see it? So in the case of Houston, obviously, [is a] major market in this part of the country, but also we've partnered with the museum twice before with National Archives exhibits, so we knew that they would be up to the task of handling the exhibit and the crowds."

The star of the collection is a rare engraving of the original Declaration of Independence. Secretary of State and future president John Quincy Adams commissioned 200 exact replicas of the document from engraver William J. Stone in 1823. Less than 50 now remain. Madden joyfully pointed out that there are errors in this document, a potent reminder that the men who forged a nation made mistakes.

"There's a couple of typos in it where they had to make corrections," said Madden. "So even the founders, you know, they're all human. That resonates because here these people are making this move against the most powerful nation in the world and putting their lives on the line for a country based on ideas."

Other impressive parts of the collection include official Oaths of Allegiance signed by George Washington, Aaron Burr, and Alexander Hamilton, as well as one of the drafts of the Bill of Rights. Many states would not ratify the Constitution until certain rights were included in the document, leading to Washington going on a national tour assuring state leaders enshrining protections was first on the list. The draft copy on display specifically shows the First Amendment in progress.

Houston is the fourth stop on the exhibition's tour, which will take the documents to Denver, Miami, Dearborn, and Seattle through the summer. Freedom Plane is just one part of a larger patriotic celebration at the HMNS, which includes a film series celebrating American science and culture and general Americana decoration throughout the main hall.

Admission to Freedom Plane is free to the public, but separate from general admission to the museum. Space is limited, and passes are available on a first-come, first-serve basis. Non-members should expect long waits or the possibility that the day's passes are sold out. Only museum members can reserve passes for specific times. Flash photography is prohibited due to the fragile nature of the documents.

---

This article originally appeared on CultureMap.com.